Duration of Therapy: Clinical Trials

18 trials of Duration of Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 1 terminated. 18 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 418Completed 17, Terminated 1

Follow Duration of Therapy: new trials by email Literature Review of Duration of Therapy trials Research Report on Duration of Therapy

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A De-Escalating Strategy for Antibiotic Treatment of Pneumonia in The Medical Intensive Care Unit (0787B-092)
MK0787B, imipenem/cilastatin sodium / Duration of Treatment: 7 Days, Comparator: amikacin / Duration of Treatment: 3 Days, Comparator: tazocin / Duration of Treatment: 3 Days - Infection, Pneumonia
Phase 4CompletedMerck Sharp & Dohme LLC1202006-11-012017-02-17
Quality of Life With Arcoxia in Women With Dysmenorrhea (0663-094)
MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days - Pain
Phase 4CompletedOrganon and Co3372005-09-012024-08-15
To Evaluate the Lipid-Lowering Efficacy and Safety of Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia (0733-264)
MK0733, simvastatin / Duration of Treatment: 12 Weeks - Hypercholesterolemia
Phase 4CompletedOrganon and Co302005-05-012024-08-15
Analgesic Treatment Mediated by Arcoxia (0663-093)
MK0663, Arcoxia, etoricoxib / Duration of Treatment: 3 Days - Pain
Phase 4CompletedOrganon and Co2372005-04-012022-02-16
Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks - Asthma, Rhinitis Allergic
Phase 4CompletedOrganon and Co912005-03-182024-08-15
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks - Essential Hypertension
Phase 4CompletedOrganon and Co1742005-02-052024-08-15
A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)
MK0663; etoricoxib / Duration of Treatment: 5 Days, Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days - Acute Gout
Phase 4CompletedOrganon and Co1802005-01-012024-08-15
Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)
MK0663, etoricoxib / Duration of Treatment: 4 weeks, Comparator: diclofenac / Duration of Treatment: 4 weeks - Chronic Low Back Pain
Phase 4CompletedOrganon and Co4012004-06-012022-02-15
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)
MK0869, aprepitant / Duration of Treatment: 3 days, Comparator: ondansetron / Duration of Treatment: 4 days - Nausea, Vomiting
Phase 4CompletedMerck Sharp & Dohme LLC4772004-01-132017-04-24
Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
MK0476, montelukast sodium / Duration of Treatment: 4 Weeks, Comparator: ketotifen / Duration of Treatment: 4 Weeks - Asthma
Phase 4CompletedOrganon and Co1882003-09-252024-08-15
A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)
MK0476; montelukast sodium/Duration of Treatment: 16 weeks, Comparator: theophylline ER/Duration of Treatment: 16 weeks - Asthma, Allergic Rhinitis
Phase 4CompletedOrganon and Co312003-02-012024-08-15
Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)
MK0954, losartan potassium/Duration of Treatment: 18 weeks, Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks - Hypertension
Phase 4CompletedOrganon and Co1202003-02-012024-08-15
An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)
MK0869, aprepitant / Duration of Treatment: 3 days, Comparator: ondansetron / Duration of Treatment: 3 days - Nausea, Vomiting
Phase 4CompletedMerck Sharp & Dohme LLC8662002-10-102017-05-05
First Step With Singulair® Therapy (0476-323)
MK0476 (singulair), montelukast sodium / Duration of Treatment: 6 Weeks, Comparator: Fluticasone / Duration of Treatment: 6 Weeks - Asthma
Phase 4CompletedOrganon and Co3992002-09-012024-08-15
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
MK0966; rofecoxib / Duration of Treatment: 24 weeks, Comparator: placebo / Duration of Treatment: 24 weeks - Adenomatous Polyposis Coli
Phase 4TerminatedMerck Sharp & Dohme LLC622002-08-062019-09-20
Linear Growth Study (0476-097)(COMPLETED)
MK0476, montelukast sodium / Duration of Treatment : 56 Weeks, Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weeks - Asthma
Phase 4CompletedOrganon and Co3602000-06-012024-08-14
Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)
MK0954, losartan potassium/Duration of Treatment: 20 weeks, Comparator: amlodipine / Duration of Treatment: 20 weeks - Renal Disorder
Phase 4CompletedOrganon and Co972000-02-012022-02-16
A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
MK0476; montelukast sodium/Duration of Treatment: 16 weeks, Comparator: placebo / Duration of Treatment: 16 weeks - Asthma
Phase 4CompletedOrganon and Co5461998-03-012022-02-02

Conditions studied

Asthma (6)  ·  Nausea (2)  ·  Pain (2)  ·  Vomiting (2)  ·  Adenomatous Polyposis Coli (1)  ·  Breast Neoplasms (1)  ·  Cancer Pain (1)  ·  Essential Hypertension (1)  ·  Hypercholesterolemia (1)  ·  Hypertension (1)  ·  Infections (1)  ·  Kidney Diseases (1)  ·  Osteoarthritis (1)  ·  Pneumonia (1)  ·  Rhinitis, Allergic (1)

Sponsors

Organon and Co (14)  ·  Merck Sharp & Dohme LLC (4)

Countries

Taiwan (1)

Results publications

PMID 12612294, PMID 12937228, PMID 17588299, PMID 19949604